Möchten Sie immer auf dem neuesten Stand bleiben?
Erstellen Sie noch heute ein Leserkonto, um die Branchen und Unternehmen zu verfolgen, die Sie interessieren, und passen Sie Ihr Nachrichten-Dashboard an.
-
7th Avenue opens at King of Prussia Mall, expanding its Philadelphia-area footprint and marking its first showroom with Simon Property Group.
-
KISSIMMEE, Fla., April 09, 2026 (GLOBE NEWSWIRE) -- Aureus Greenway Holdings Inc. (Nasdaq: AGH) (the “Company”) today announced that Autonomous Power Corporation, doing business as “Powerus”, its...
-
Austin, United States, April 09, 2026 (GLOBE NEWSWIRE) -- As per the SNS Insider Report, The Endometriosis Treatment Market size was valued at USD 2.14 billion in 2025 and is expected to reach USD...
-
MALVERN, Pa., April 09, 2026 (GLOBE NEWSWIRE) -- Annovis Bio, Inc. (NYSE: ANVS) (“Annovis” or the “Company”), a Phase 3 clinical-stage biotechnology company developing the investigational oral...
-
VANCOUVER, British Columbia, April 09, 2026 (GLOBE NEWSWIRE) -- ZenaTech, Inc. (Nasdaq: ZENA) (FSE: 49Q) (BMV: ZENA) ("ZenaTech"), a technology solution provider specializing in AI (Artificial...
-
NEW YORK, April 09, 2026 (GLOBE NEWSWIRE) -- Nuvini Group Limited (Nasdaq: NVNI) ("Nuvini" or the "Company"), a leading acquirer and operator of profitable software businesses across the Americas,...
-
DENVER, April 09, 2026 (GLOBE NEWSWIRE) -- American Rare Earths (ASX: ARR | OTCQX: ARRNF | ADR: AMRRY) (“ARR” or the “Company”) is pleased to announce the next stage in its accelerated pilot plant...
-
TORONTO, April 09, 2026 (GLOBE NEWSWIRE) -- NowVertical Group Inc. (TSX-V: NOW) (“NOW” or the “Company”), a leader in AI-driven data solutions, announces financial results for its fourth fiscal...
-
WUXI, China, April 09, 2026 (GLOBE NEWSWIRE) -- LOBO TECHNOLOGIES LTD. (NASDAQ: LOBO) (“LOBO” or the “Company”), an innovative electric mobility vehicles manufacturer and seller, today announced the...
-
BMC Psychiatry publication reports statistically significant reductions in self-injury behaviors and depressive symptoms, with brain-network findings further supporting Nexalin’s differentiated,...